Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately to Severely Active Crohns Disease”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Testing effectiveness (Phase 2)Ended earlyNCT00329537
What this trial is testing

Study of Sargramostim in Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Genzyme, a Sanofi Company 11
Testing effectiveness (Phase 2)Study completedNCT01576471
What this trial is testing

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo

Who this might be right for
Crohn's Disease
Coronado Biosciences, Inc. 250
Testing effectiveness (Phase 2)Ended earlyNCT03635112
What this trial is testing

Efficacy and Safety of TD-1473 in Crohn's Disease

Who this might be right for
Crohn's Disease
Theravance Biopharma 167
Testing effectiveness (Phase 2)Study completedNCT02513459
What this trial is testing

A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
AbbVie 65
Testing effectiveness (Phase 2)Ended earlyNCT02574637
What this trial is testing

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AstraZeneca 29
Large-scale testing (Phase 3)Study completedNCT03357471
What this trial is testing

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more
UCB Biopharma S.P.R.L. 70
Testing effectiveness (Phase 2)Ended earlyNCT02405442
What this trial is testing

Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Gilead Sciences 187
Large-scale testing (Phase 3)Ended earlyNCT02403323
What this trial is testing

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Who this might be right for
Crohn Disease
Hoffmann-La Roche 790
Testing effectiveness (Phase 2)Study completedNCT02015793
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 30
Large-scale testing (Phase 3)Study completedNCT03105128
What this trial is testing

The Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 931
Testing effectiveness (Phase 2)UnknownNCT02465944
What this trial is testing

A Pilot Study of FFP104 in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Fast Forward Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT01466374
What this trial is testing

Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Bristol-Myers Squibb 121
Large-scale testing (Phase 3)Study completedNCT03345849
What this trial is testing

The Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies

Who this might be right for
Crohn's Disease
AbbVie 526
Large-scale testing (Phase 3)Looking for participantsNCT07196722
What this trial is testing

Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 1,092
Testing effectiveness (Phase 2)Ended earlyNCT05068284
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 176
Post-approval studies (Phase 4)Looking for participantsNCT07564505
What this trial is testing

A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's Disease

Who this might be right for
Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Early research (Phase 1)Study completedNCT02968108
What this trial is testing

A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 45
Testing effectiveness (Phase 2)Ended earlyNCT00584740
What this trial is testing

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT00207662
What this trial is testing

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 580
Large-scale testing (Phase 3)Study completedNCT03234907
What this trial is testing

Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.

Who this might be right for
Crohn's Disease
Takeda 215
Next Page